Pulmonary hypertension during respiratory syncytial virus bronchiolitis: a risk factor for severity of illness

Abstract Background: Respiratory syncytial virus infection is the most frequent cause of acute lower respiratory tract disease in infants. A few reports have suggested that pulmonary hypertension is associated with increased severity of respiratory syncytial virus infection. We sought to determine the association between the pulmonary hypertension detected by echocardiography during respiratory syncytial virus bronchiolitis and clinical outcomes. Methods: We retrospectively reviewed 154 children admitted with respiratory syncytial virus bronchiolitis who had an echocardiography performed during the admission. The association between pulmonary hypertension and clinical outcomes including mortality, intensive care unit (ICU) admission, prolonged ICU stay (>10 days), tracheal intubation, and need of high frequency oscillator ventilation was evaluated. Results: Echocardiography detected pulmonary hypertension in 29 patients (18.7%). Pulmonary hypertension was observed more frequently in patients with congenital heart disease (CHD) (n = 11/33, 33%), chronic lung disease of infancy (n = 12/25, 48%), prematurity (<37 weeks gestational age, n = 17/59, 29%), and Down syndrome (n = 4/10, 40%). The presence of pulmonary hypertension was associated with morbidity (p < 0.001) and mortality (p = 0.02). However, in patients without these risk factors (n = 68), pulmonary hypertension was detected in five patients who presented with shock or poor perfusion. Chronic lung disease was associated with pulmonary hypertension (OR = 5.9, 95% CI 2.2–16.3, p = 0.0005). Multivariate logistic analysis demonstrated that pulmonary hypertension is associated with ICU admission (OR = 6.4, 95% CI 2.2–18.8, p = 0.0007), intubation (OR = 4.7, 95% CI 1.8–12.3, p = 0.002), high frequency oscillator ventilation (OR = 8.4, 95% CI 2.95–23.98, p < 0.0001), and prolonged ICU stay (OR = 4.9, 95% CI 2.0–11.7, p = 0.0004). Conclusions: Pulmonary hypertension detected by echocardiography during respiratory syncytial virus infection was associated with increased morbidity and mortality. Chronic lung disease was associated with pulmonary hypertension detected during respiratory syncytial virus bronchiolitis. Routine echocardiography is not warranted for previously healthy, haemodynamically stable patients with respiratory syncytial virus bronchiolitis.

[1]  J. Castro‐Rodriguez,et al.  Down Syndrome and the Risk of Severe RSV Infection: A Meta-analysis , 2018, Pediatrics.

[2]  S. Nadel,et al.  Characteristics of children admitted to intensive care with acute bronchiolitis , 2018, European Journal of Pediatrics.

[3]  M. Lucero,et al.  Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study , 2017, The Lancet.

[4]  E. Randle,et al.  G441 Bronchiolitis in picu: who struggles to survive? , 2017, Archives of Disease in Childhood.

[5]  J. Aboulhosn,et al.  Pulmonary Hypertension and Congenital Heart Disease. , 2016, Cardiology clinics.

[6]  C. Rodríguez‐Martínez,et al.  Predictors of severe disease in a hospitalized population of children with acute viral lower respiratory tract infections , 2016, Journal of medical virology.

[7]  U. Krishnan,et al.  Pulmonary hypertension in chronic lung disease of infancy , 2015, Current opinion in pediatrics.

[8]  J. Padbury,et al.  Pulmonary hypertension in preterm infants: prevalence and association with bronchopulmonary dysplasia. , 2014, The Journal of pediatrics.

[9]  P. Mourani,et al.  Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond , 2013, Current opinion in pediatrics.

[10]  J. Jung Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey , 2011, Korean journal of pediatrics.

[11]  M. Lanari,et al.  Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes. , 2009, Paediatric respiratory reviews.

[12]  K. Thorburn Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection , 2008, Archives of Disease in Childhood.

[13]  P. Mourani,et al.  Clinical Utility of Echocardiography for the Diagnosis and Management of Pulmonary Vascular Disease in Young Children With Chronic Lung Disease , 2008, Pediatrics.

[14]  V. Aiello,et al.  Respiratory syncytial virus as a trigger of a pulmonary hypertensive crisis after operative correction of aortic coarctation , 2007, Cardiology in the Young.

[15]  R. Welliver Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. , 2003, The Journal of pediatrics.

[16]  E. Simões Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. , 2003, The Journal of pediatrics.

[17]  S. Johnston,et al.  Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. , 2003, American journal of respiratory and critical care medicine.

[18]  Y. Poovorawan,et al.  Plasma endothelin-1 in infants and young children with acute bronchiolitis and viral pneumonia. , 2002, Asian Pacific journal of allergy and immunology.

[19]  C. Rohlicek,et al.  Quantifying pulmonary hypertension in ventilated infants with bronchiolitis: A pilot study , 2001, Journal of Paediatrics and Child Health.

[20]  J. Englund,et al.  Respiratory Syncytial Virus in Patients with Congenital Heart Disease: A Contemporary Look at Epidemiology and Success of Preoperative Screening , 2000, Pediatric Cardiology.

[21]  J. Wain,et al.  Pulmonary hypoxia increases endothelin-1 gene expression in sheep. , 1994, The Journal of surgical research.

[22]  J. Meliones,et al.  Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: A recent experience , 1992, Critical care medicine.

[23]  E. Wang,et al.  Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. , 1992, The Journal of pediatrics.

[24]  F. de Zegher,et al.  Respiratory syncytial virus infection in infants with unequal pulmonary perfusion. , 1991, The New England journal of medicine.

[25]  S. Hunter,et al.  Cardiovascular Effects of Acute Bronchiolitis , 1991, Acta paediatrica Scandinavica.

[26]  C. Hall,et al.  Respiratory syncytial viral infection in infants with congenital heart disease. , 1982, The New England journal of medicine.

[27]  Luiza Bardi-Peti,et al.  Pulmonary hypertension during acute respiratory diseases in infants. , 2010, Maedica.

[28]  John B. West,et al.  Pulmonary Pathophysiology: The Essentials , 1982 .